Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples